Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers [Phase 1]
Phase 1 safety study update for PF-08046044/SGN-35C in adults with advanced cancers; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. [Phase 1, Phase 2]
This document describes a Phase 1/Phase 2 clinical trial evaluating AZD3470 as a monotherapy or in combination with other anticancer agents …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study of Lacutamab in Peripheral T-cell Lymphoma [Phase 2]
A Phase 2 study evaluating lacutamab for Peripheral T-cell lymphoma (including relapsed/recurrent disease) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma [Phase 1]
A first-in-human Phase 1 study of KK2223 in relapsed or refractory T-cell non-Hodgkin lymphoma (PTCL or CTCL) is planned, with the trial cur…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma [Phase 2]
An ongoing Phase 2 study evaluating maintenance therapy with ruxolitinib after hematopoietic stem cell transplant in patients with T-cell ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas [Phase 1]
Phase 1 clinical trial update for constitutive IL7R (C7R) modified banked allogeneic CD30.CAR EBVSTs in CD30-positive lymphomas, currently r…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma [Phase 1]
This clinical trial update discusses MEDI-570, an anti-ICOS monoclonal antibody, in relapsed or refractory peripheral T-cell lymphoma follic…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma [Phase 1]
A Phase 1 clinical trial is evaluating intravenous vesicular stomatitis virus in patients with peripheral T-cell lymphoma and related condit…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with decitabine and pralatrexate for peripheral T-cell lymphoma and cutaneous T-cell l…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating genotype-guided targeted agents plus an EZH2 inhibitor in primary refractory peripheral T-cell lymphom…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 trial is evaluating the combination of sintilimab and chidamide for peripheral T-cell lymphoma, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers [Phase 1]
Phase 1 clinical trial update for PF-08046032 in people with advanced cancers; the study is currently active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2026-04-01Clinical Trial Update: Tazemetostat Plus CHOP in 1L T-cell Lymphoma [Phase 2]
A Phase 2 trial evaluating tazemetostat in combination with CHOP for first-line T-cell lymphomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma [Phase 3]
A Phase 3 clinical trial is evaluating golidocitinib versus placebo as maintenance therapy for peripheral T-cell lymphoma and is currently r…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating allogeneic hematopoietic cell transplantation for peripheral T-cell lymphoma; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating a four-drug regimen (romidepsin, gemcitabine, dexamethasone, cisplatin) in peripheral T-cell lymphoma and diffuse l…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma [Phase 2]
An exploratory Phase 2 study evaluating SHR-0302 and SHR-2554 in patients with relapsed or refractory peripheral T-cell lymphoma is currentl…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study
Fudan University is conducting a multicenter retrospective and prospective cohort study to assess real-world outcomes in patients with Perip…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma [Phase 1]
An exploratory Phase 1 trial is evaluating umbilical cord blood–derived CAR-NK cells targeting TRBC1/2 in patients with relapsed or refracto…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
This clinical trial is testing a stratified therapy approach for peripheral T-cell lymphoma after patients respond to first-line treatment. …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Karyopharm Expanded Access Program for Selinexor
This update covers Karyopharm's Expanded Access Program for selinexor (Xpovio), including eligibility and current availability for listed ca…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma [Phase 1, Phase 2]
Phase I/II study of ASTX660 in relapsed or refractory T-cell lymphomas has been terminated; results have been posted.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating golidocitinib vs placebo as maintenance therapy for Peripheral T-cell lymphoma patients who achieved a r…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) [Phase 1]
Phase 1 study assessing Tolinapant with oral decitabine/cedazuridine and decitabine/cedazuridine alone in relapsed/refractory peripheral T-c…